Natalizumab wearing-off symptoms: effect of extend interval dosing during Sars-CoV-2 pandemic. Magro G, Barone S, Tosto F, De Martino A, et al. J Neurol 2023;270:595-600.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Magro G, Barone S, Tosto F, De Martino A, et al. Natalizumab wearing-off symptoms: effect of extend interval dosing during Sars-CoV-2 pandemic. J Neurol 2023;270:595-600.
PMID: 36229702